miR-101 sensitizes K562 cell line to imatinib through Jak2 downregulation and inhibition of NF-κB target genes.
about
Liver X receptors agonist GW3965 re-sensitizes gefitinib-resistant human non-small cell lung cancer cell to gefitinib treatment by inhibiting NF-κB in vitro.Sporamin induces apoptosis and inhibits NF-κB activation in human pancreatic cancer cells.The effects of miRNA-1180 on suppression of pancreatic cancer.Targeting microRNA/UHRF1 pathways as a novel strategy for cancer therapy.
P2860
miR-101 sensitizes K562 cell line to imatinib through Jak2 downregulation and inhibition of NF-κB target genes.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
miR-101 sensitizes K562 cell l ...... ibition of NF-κB target genes.
@en
type
label
miR-101 sensitizes K562 cell l ...... ibition of NF-κB target genes.
@en
prefLabel
miR-101 sensitizes K562 cell l ...... ibition of NF-κB target genes.
@en
P2093
P2860
P1433
P1476
miR-101 sensitizes K562 cell l ...... hibition of NF-κB target genes
@en
P2093
Elham Farhadi
Farhad Zaker
Mohammad Reza Rezvani
P2860
P2888
P304
14117-14128
P356
10.1007/S13277-016-5205-9
P50
P577
2016-08-12T00:00:00Z
P6179
1035439799